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Stem cell specification in multicellular organisms relies on the precise
spatiotemporal control of RNA polymerase II (Pol II)-dependent gene
transcription, in which the evolutionarily conserved Mediator coac-
tivator complex plays an essential role. InArabidopsis thaliana, SHORT-
ROOT (SHR) and SCARECROW (SCR) orchestrate a transcriptional
program that determines the fate and asymmetrical divisions of stem
cells generating the root ground tissue. The mechanism bywhich SHR/
SCR relays context-specific regulatory signals to the Pol II general tran-
scription machinery is unknown. Here, we report the role of Mediator
in controlling the spatiotemporal transcriptional output of SHR/SCR
during asymmetrical division of stem cells and ground tissue pattern-
ing. The Mediator subunit MED31 interacted with SCR but not SHR.
Reduction of MED31 disrupted the spatiotemporal activation of
CYCLIND6;1 (CYCD6;1), leading to defective asymmetrical division of
stem cells generating ground tissue. MED31 was recruited to the pro-
moter of CYCD6;1 in an SCR-dependent manner. MED31 was involved
in the formation of a dynamic MED31/SCR/SHR ternary complex
through the interface protein SCR. We demonstrate that the relative
protein abundance of MED31 and SHR in different cell types regulates
the dynamic formation of the ternary complex, which provides a tun-
able switch to strictly control the spatiotemporal transcriptional out-
put. This study provides valuable clues to understand the mechanism
by which master transcriptional regulators control organ patterning.
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In the reference plant Arabidopsis thaliana, the primary root iscomposed of single-cell layers of epidermis, cortex, endoder-
mis, and pericycle surrounding the vascular tissues (1). This regular
pattern is established and maintained by different sets of stem cells
residing in the root meristem. These stem cells surround a group of
mitotically less active quiescent center (QC) cells (2). QC cells and
the actively dividing stem cells form a specialized cellular micro-
environment called the stem cell niche (3–7). Within the stem cell
niche, the cortex/endodermis initials (CEI) and their immediate
daughter cells (CEID) undergo formative asymmetrical cell di-
vision (ACD) to generate the separate endodermis and cortex cell
layers, which collectively constitute the ground tissue (3–7).
As in animal systems, the gene expression program that deter-
mines stem cell fate and organ patterning in plants is controlled by a
small number of master transcription factors (6, 7). SHORTROOT
(SHR) and SCARECROW (SCR) play critical roles in ground
tissue patterning by controlling the proper specification, mainte-
nance, and ACD of the CEI and/or CEID (8–12). Mutations of
SHR and SCR lead to related defects in ground tissue patterning
(8–12). SHR is transcriptionally expressed in the stele, and the
encoded protein moves to the outer adjacent cell layer, where SCR
sequesters SHR to the nucleus by forming an SHR/SCR complex
(13). This complex orchestrates a transcriptional program that
controls the spatiotemporal ACD of the CEI and/or CEID for
ground tissue patterning (14–17).
Direct transcriptional targets of the SHR/SCR complex have
been identified. A group of plant-specific INDETERMINATE
DOMAIN C2H2 zinc finger transcription factors (BIRD) are
transcriptional targets of the SHR/SCR complex during ground
tissue specification and patterning (18–21). Several members of the
BIRD family, including JACKDAW (JKD) and MAGPIE (MGP),
physically interact with SHR and/or SCR, suggesting that these
proteins are important players in the SHR/SCR complex (19–23).
CYCLIND6;1 (CYCD6;1), whose temporal expression coincides
with the onset of specific ACDs of the CEID that pattern the ground
tissue, is a direct transcriptional target of the SHR/SCR complex
(24). The spatiotemporal activation of CYCD6;1 is controlled by a
bistable switch involving SHR, SCR, and the cell differentiation
factor RETINOBLASTOMA-RELATED (RBR) (25).
Despite these research advances, the precise mechanism un-
derlying SHR/SCR-mediated transcriptional regulation remains
enigmatic. In particular, the process by which SHR/SCR relays
regulatory signals to the RNA polymerase II (Pol II) general
transcription machinery to transcribe specific genes in a cell type-
and developmental stage-specific manner remains unclear.
Mediator is an evolutionarily conserved, multisubunit coactivator
complex that is essential for Pol II-dependent gene transcription
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(26–31). Since its identification in yeast (32, 33) and animals (34),
Mediator has been extensively investigated for its ability to or-
chestrate the transcription factor-dependent assembly of the Pol
II preinitiation complex (PIC) via discrete interactions with
signal-dependent transcription factors and Pol II (26–29). Novel
functions are continuously ascribed to the yeast and animal
Mediator in controlling almost every stage of Pol II-dependent
gene transcription, including epigenetic regulation, transcrip-
tional elongation and termination, mRNA processing, noncoding
RNA activation, and chromatin loop formation (28, 30, 31, 35–
37). These functions suggest that Mediator acts as a pivotal co-
ordinator of transcriptional regulation.
The plant Mediator complex was not biochemically isolated
until 2007 (38). Despite the identification of a number of plant
Mediator subunits that are implicated in the regulation of plant
development and adaptive responses (39–47), mechanistic stud-
ies on the functions of plant Mediator are still in their infancy.
Considering the essential role of Mediator in bridging the cross-
talk between gene-specific transcription factors and the general
transcription machinery during gene transcription, we hypothesized
that a specific Mediator subunit might directly interact with SHR
and/or SCR. Notably, we found that the plant Mediator subunit
MED31 directly interacts with SCR but not with SHR. Here, we
report that MED31 plays an essential role in SHR/SCR-directed
spatiotemporal activation of CYCD6;1 and ground tissue patterning.
Genetic and biochemical analyses indicated that MED31 is involved
in the formation of a ternary MED31/SCR/SHR transcription
complex, and this ternary complex is dynamic because MED31 and
SHR compete for binding to SCR. The dynamic interaction of
MED31 with SCR determines the transcriptional output of the
SHR/SCR transcription complex, which spatiotemporally coincides
with stem cell ACD during ground tissue patterning.
Results
MED31 Directly Interacts with SCR but Not SHR. The direct linkage
between the SHR/SCR complex and the Pol II transcription
machinery was examined by designing a yeast two-hybrid assay to
identify Mediator subunits interacting with SHR and/or SCR.
For this purpose, SHR or SCR was fused to the GAL4 activation
domain as bait to screen a library of Arabidopsis Mediator subunits.
The results showed that MED31 interacted with SCR but not SHR
(Fig. 1A and SI Appendix, Fig. S1 A and B). To confirm these ob-
servations, in vitro pull-down experiments were performed using
purified maltose-binding protein (MBP)–tagged MED31 (MED31-
MBP) and FLAG epitope-tagged SHR (SHR-FLAG) or SCR
(SCR-FLAG). MED31-MBP pulled down SCR-FLAG but not
SHR-FLAG (Fig. 1B), indicating that MED31 interacted with SCR
in vitro. Domain mapping indicated that the highly conserved N-
terminal domain of MED31 (SI Appendix, Fig. S1 C and D) and the
central domain (CD) of SCR were involved in the MED31/SCR
interaction (Fig. 1 C andD). Considering that the CD of SCR is also
responsible for its interaction with SHR (16), these results suggested
that MED31 and SHR may bind to the same domain of SCR.
To determine whether MED31 interacts with SCR in planta, we
conducted firefly luciferase (LUC) complementation imaging (48)
assays in Nicotiana benthamiana leaves. MED31 and SCR were
fused to the N- and C-terminal halves of LUC, respectively. N.
benthamiana cells coexpressing MED31-nLUC and cLUC-SCR
displayed strong fluorescence signals, whereas those coexpress-
ing nLUC and cLUC-SCR or MED31-nLUC and cLUC displayed
no signal (Fig. 1E), confirming that the MED31/SCR interaction
occurred in vivo.
Next, we performed reciprocal coimmunoprecipitation (co-IP)
experiments in N. benthamiana leaves, which showed that green
fluorescent protein (GFP)-tagged SCR (SCR-GFP) was immu-
noprecipitated by MED31-myc and vice versa (Fig. 1F). In co-IP
assays using SCR-GFP plants and anti-MED31 antibodies, native
MED31 was pulled down by SCR-GFP, confirming the interaction
between MED31 and SCR in planta (Fig. 1G). Taken together,
these results indicated that MED31 directly interacts with SCR
but not SHR; therefore, we next investigated the potential role of
MED31 in SHR/SCR-directed gene transcription and ground
tissue patterning.
Knockdown of MED31 Impairs Ground Tissue Patterning. Phyloge-
netic analyses indicated that MED31 is conserved among plant
species as well as in yeast and animals (SI Appendix, Fig. S1 C
and D). The sequence conservation of MED31 resides within an
∼69-aa N-terminal motif that contains a remarkable number of
absolutely conserved residues (49) (SI Appendix, Fig. S1C). No-
tably, it has been shown that MED31 is essential for mammalian
development by controlling cell fate establishment and cell
proliferation during early embryogenesis (50, 51).
Fusion of promoter and GUS (β-glucuronidase) indicated that
MED31 is richly expressed in the root meristem (SI Appendix,
Fig. S2 A and B) and that a MED31-GFP fusion protein local-
ized to the nucleus (SI Appendix, Fig. S2C). Interestingly, we
found that treatment with the protein synthesis inhibitor cyclo-
heximide led to reduced MED31 protein abundance, whereas
treatment with the proteasome inhibitor MG132 led to increased
MED31 protein abundance (SI Appendix, Fig. S2 D–G), suggesting
that MED31 is subject to proteasome-dependent degradation. The
physical interaction of MED31 with SCR prompted us to investigate
the potential role of MED31 in root radial patterning using a ge-
netic approach. An efficient CRISPR/Cas9 gene editing system (52)
was used to generate the knockout mutant med31-c (SI Appendix,
Fig. S3 A–E). The med31-c mosaic mutants showed defective root
growth (SI Appendix, Fig. S3 F–J). Homozygous med31-c mutants
showed an embryonic lethal phenotype, which could be com-
plemented by aMED31-GFP fusion driven by theMED31 promoter
(pMED31::MED31:GFP) (SI Appendix, Fig. S3 B–D′). These results
indicated that Arabidopsis MED31 plays an essential role in early
embryo development.
RNA interference (RNAi) was used to generate a collection of
MED31-RNAi lines (the RNAi strategy is described in SI Appen-
dix). We obtained multiple lines with similar short root pheno-
types, coinciding with their reductions of MED31 transcript (SI
Appendix, Fig. S4). The MED31-RNAi line L28, in which MED31
expression was substantially reduced at both the transcript and
protein levels (SI Appendix, Fig. S4 A and B), was designated as
MED31-RNAi and used for further analyses.
Similar to the shr-1 and scr-1 mutants (8, 9, 11, 12), MED31-
RNAi plants showed stunted root growth and reduced root meri-
stem size (Fig. 2 A–C). In the stem cell niche of wild-type (WT)
roots, the CEI divides anticlinally and generates the CEID (Fig. 2
D and E). The CEID then undergoes periclinal ACD and gen-
erates an inner layer of endodermis and an outer layer of cortex,
constituting the well-organized ground tissue (Fig. 2 D and E).
Considering that SCR plays a critical role in stem cell ACD and
ground tissue patterning, we investigated whether MED31-RNAi
roots showed similar defects. In the presumptive stem cell region
of MED31-RNAi roots, the regular ACD pattern of the CEI and
CEID was disrupted, despite the fact that no obvious delayed
ACD of the CEI was observed (Fig. 2 E and F). In the upper
ground tissue region of MED31-RNAi roots, the regular cellular
organization was also disrupted (Fig. 2 E and F). Notably, the
aberrant ground tissue patterning in MED31-RNAi roots corre-
lated with nonstereotyped cell shapes as well as extra cell layers
(Fig. 2 E and F).
Closer observation revealed an obvious delayed ACD of the
CEI inmed31-c mosaic lines compared with the WT (SI Appendix,
Fig. S3G andH, arrowheads). We also observed severe patterning
defects in the upper ground tissue region of med31-c mosaic roots
(SI Appendix, Fig. S3 I and J, arrowheads). Together, these results
revealed that knockdown of MED31 leads to aberrant ground
tissue patterning.
















To better visualize these patterning defects, several cell type-
specific markers were introduced into the MED31-RNAi back-
ground. Expression of J0571 (24, 53), which is specifically
expressed in the endodermal and cortical layers of WT roots
(Fig. 2G), was dramatically reduced in MED31-RNAi roots (Fig.
2 H and I, arrows). Misshaped cortex cells with a disorganized
cellular arrangement were observed in MED31-RNAi roots, and
the expression of J0571 in these irregular cells was reduced or
Fig. 1. MED31 directly interacts with SCR but not SHR. (A) Yeast two-hybrid (Y2H) assays showing that MED31 interacts with SCR but not SHR. The yeast
transformants were dropped onto SD/-Trp/-Leu (SD/-2) and SD/-4 media to assess protein–protein interactions. AD, GAL4 activation domain. (B) In vitro pull-
down assays showing that MED31 directly interacts with SCR but not SHR. SCR-FLAG was pulled down by MED31-MBP immobilized on amylose resin. Protein
bound to amylose resin was eluted and analyzed by anti-FLAG antibody. CBB, Coomassie brilliant blue staining; MW, molecular weight (mass). (C) Domains of
MED31 involved in the MED31/SCR interaction were mapped using Y2H assays. Yeast cells cotransformed with pGBKT7-MED31 or pGBKT7-MED31 derivatives
(baits) and pGADT7-SCR (prey) were dropped onto SD/-2 and SD/-4 media to assess interactions with SCR. CD, C-terminal domain; ND, N-terminal domain. (D)
Domains of SCR involved in the MED31/SCR interaction were mapped using the Y2H assay. Yeast cells cotransformed with pGADT7-SCR or pGADT7-SCR
derivatives (baits) and pGBKT7-MED31 (prey) were dropped onto SD/-2 and SD/-4 media to assess interactions with MED31. CD, central domain; ND, N-variable
domain; PS, PFYRE/SAW domain. (E, Top) LUC complementation imaging assays showing that MED31 interacts with SCR. (E, Bottom) N. benthamiana leaves
coinfiltrated with the different combinations are shown. The pseudocolor bar shows the range of luminescence intensity. (F) Co-IP assays of MED31 with SCR
in N. benthamiana. MED31-myc and SCR-GFP were coinfiltrated into N. benthamiana leaves. Protein samples were immunoprecipitated with anti-myc an-
tibody and immunoblotted with anti-GFP antibody (Top) or immunoprecipitated with anti-GFP antibodies and immunoblotted with anti-myc antibodies
(Bottom). (G) Co-IP assays of MED31 with SCR in Arabidopsis. Protein extracts from 6 dags after germination (DAG) WT and SCR-GFP seedlings were
immunoprecipitated with anti-GFP antibodies. For F and G, samples before (input) and after immunoprecipitation (IP) were immunoblotted with the in-
dicated antibodies. All experiments in A–G were repeated at least three times with similar results.
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undetectable (Fig. 2I, arrowheads). Similarly, the general ex-
pression levels of pCO2::H2B:YFP (15), which is specifically
expressed in the cortical layer of WT roots (Fig. 2J), were also
markedly reduced in MED31-RNAi roots (Fig. 2K, arrows). Ec-
topic cells were observed between the endodermis and cortex
layers in MED31-RNAi roots, and the expression of pCO2::H2B:
YFP was almost undetectable in these supernumerary cells (Fig.
2K, arrowheads). Taken together, these observations indicated
that MED31 plays a critical role in regulating cell-type specifi-
cation and ground tissue patterning.
MED31 Acts in the SHR/SCR Pathway to Regulate Ground Tissue
Patterning. Considering the established role of SHR and SCR in
ground tissue patterning, we compared the expression of SHR
and SCR betweenMED31-RNAi and WT. Reverse transcription-
quantitative PCR (RT-qPCR) assays indicated that the SHR
transcript levels did not show a significant change in MED31-
RNAi roots (Fig. 3A). We then transferred the pSHR::SHR:GFP
protein fusion (14) into MED31-RNAi and measured SHR-GFP
fluorescence in the stele, which is the source of the mobile SHR
protein. The levels of SHR-GFP fluorescence displayed negli-
gible alteration in the stele of MED31-RNAi roots (Fig. 3 B–E).
To ask whether MED31 plays a role in SHR movement into the
endodermal cells, we measured the SHR-GFP fluorescence ratio
between the endodermis and the stele as previously described
(54). In 5-d-old WT roots, the endodermal-to-stele ratio of the
SHR-GFP fluorescence was stable (∼1.0); in MED31-RNAi roots,
on the other hand, the endodermal-to-stele ratio of the SHR-GFP
fluorescence showed sporadic variations throughout the ground
tissue (0.13–1.43) (Fig. 3 B–E and SI Appendix, Fig. S5 A–D),
revealing an important function of MED31 in maintaining the
uniform distribution of the SHR protein in individual endodermal
cells. Significantly, we found that endodermal cells showing al-
tered SHR protein accumulation correlate with irregular periclinal
division, which leads to the formation of extra cell layers in
MED31-RNAi roots (Fig. 3 C and E). Closer observation revealed
that in yet-to-divide or dividing cells (before nuclear breakdown),
the endodermal-to-stele ratio of SHR-GFP was low, whereas in
recently divided cells, the endodermal-to-stele ratio of SHR-GFP
was high (Fig. 3 C and E).
We then examined whether MED31-RNAi affects SCR ex-
pression. The expression of pSCR::GFP:SCR and pSCR::GFP
was considerably lower in the endodermis of MED31-RNAi than
in the WT (Fig. 3 F and G and SI Appendix, Fig. S5 E and F).
Consistently, RT-qPCR assays showed that the transcript levels
of SCR were significantly lower in the root tips of MED31-RNAi
than in those of the WT (Fig. 3A), indicating that knockdown of
MED31 affects the expression of SCR. As SCR is a direct target
Fig. 2. Reduction ofMED31 impairs ground tissue patterning. (A) Phenotypes of the indicated genotypes at 5 DAG. (Scale bar, 5 mm.) (B) Primary root length
of the indicated genotypes at 5 DAG. (C) Quantification of the meristem cell number of the indicated genotypes at 5 DAG. Data shown are the average and
SD (n = 20) in B and C. Samples with different letters (a–d) are significantly different at P < 0.01. (D) Median longitudinal view of root stem cell niche or-
ganization and asymmetrical divisions defining the ground tissue lineage. Red, QC; blue, CEI and CEID; green, cortex (co); yellow, endodermis (en); GT, ground
tissue. The red line outlines the root stem cell niche. Modified pseudo-Schiff propidium iodide (mPS-PI) staining of WT (E) and MED31-RNAi (F) root tips at 6
DAG is shown. Red lines outline the CEI and CEID. Blue lines outline the ground tissue. (Scale bars, 50 μm.) J0571 expression in WT (G) andMED31-RNAi (H and
I) at 6 DAG is shown. White arrows indicate the abnormal expression in ground tissue of MED31-RNAi, and arrowheads indicate the irregular cell divisions in
MED31-RNAi. (Scale bars, 50 μm.) The expression pattern of pCO2::H2B:YFP in the WT (J) and MED31-RNAi (K) at 6 DAG is shown. White arrows indicate the
interrupted CO2 expression in ground tissue of MED31-RNAi, and arrowheads indicate the supernumerary cells in MED31-RNAi. (Scale bars, 50 μm.)
















of SHR/SCR (16), the reduced transcript level of SCR, in the
MED31-RNAi genotype, could be due to the compromised
transcriptional efficiency of the SHR/SCR transcription com-
plex. RT-qPCR assays showed that the expression of several
known SHR/SCR targets, including SCL3, RLK, JKD, MGP, and
NUC (21, 24), was also significantly reduced in MED31-RNAi
plants (SI Appendix, Fig. S5 G–I).
To explore the genetic relationship between MED31 and the
SHR/SCR pathway, we generated MED31-RNAi scr-1 and
MED31-RNAi shr-1 double-mutant lines. At 6 days after germi-
nation (DAG), the root growth of MED31-RNAi scr-1 was
comparable to that of scr-1 and the root growth ofMED31-RNAi
shr-1 was comparable to that of shr-1 (Fig. 2 A and B), indicating
that MED31-RNAi had no additive effects with scr-1 or shr-1 in
regulating root growth. These results support that MED31 acts
in the SHR/SCR pathway to regulate root growth.
Next, we compared the ground tissue phenotypes of the
MED31-RNAi scr-1 and MED31-RNAi shr-1 double-mutant lines
with those of their parental lines (Fig. 3 H–M′). In shr-1 and scr-1
mutants, the CEI/CEID did not divide correctly and generated a
single cell layer (Fig. 3 H, H′, J, J′, L, and L′). TheMED31-RNAi
shr-1 double mutant shared a similar phenotype of a single
ground tissue layer with shr-1 (Fig. 3 K and K′), and the MED31-
RNAi scr-1 double mutant shared a similar phenotype of a single
ground tissue layer with scr-1 as well (Fig. 3 M and M′). This
supported that MED31 acts in the SHR/SCR pathway to regu-
late ground tissue patterning.
MED31 Differentially Regulates the Expression of CYCD6;1 in the CEI
and CEID or the Upper Ground Tissue. CYCD6;1 is a direct tran-
scriptional target of SHR/SCR, and this cell cycle gene plays an
important role in stem cell ACD and ground tissue patterning
(24). In line with the irregular ACDs of the CEI and CEID (Fig.
2 E and F), the strict spatiotemporal expression pattern of
pCYCD6;1::GFP in the CEI and CEID was largely abolished in
MED31-RNAi roots (Fig. 4 A and B, 16 of 30 in WT and 30 of
35 in MED31-RNAi), indicating a critical role of MED31 in
SHR/SCR-regulated spatiotemporal activation of CYCD6;1 in
the CEI and CEID.
In contrast to the abolished pCYCD6;1::GFP expression in the
CEI and CEID, ectopic pCYCD6;1::GFP expression occurred in
the upper ground tissue in MED31-RNAi roots (Fig. 4 C and D,
five of 32 in WT and 34 of 38 in MED31-RNAi). Notably, as with
the altered accumulation of the SHR protein (Fig. 3 C and E), the
ectopic expression of pCYCD6;1::GFP in the upper endodermis
always coincided with extra periclinal divisions of these cells (Fig.
4D, arrowheads). These results indicated that MED31 negatively
regulates the expression of CYCD6;1 in the upper ground tissue.
Given that the overall expression levels of CYCD6;1 in whole
seedlings of MED31-RNAi were comparable to those in the WT
(SI Appendix, Fig. S6A), our results suggest that the altered ex-
pressions of CYCD6;1 are specifically restricted to the root tip.
To determine the genetic relationship ofMED31 and CYCD6;1
and its role in regulating ground tissue patterning, we generated a
MED31-RNAi cycd6;1 double-mutant line. The extra periclinal
divisions in the ground tissue of MED31-RNAi were largely res-
cued by cycd6;1 (SI Appendix, Fig. S6 B–F), suggesting that
MED31 functions in ground tissue patterning by regulating the
spatiotemporal expression of CYCD6;1. Taken together, the above
results indicated that MED31 plays an important role in the SHR/
SCR-mediated spatiotemporal regulation of CYCD6;1 expression
in the CEI and CEID as well as in the upper ground tissue.
MED31 Is Recruited to the CYCD6;1 Promoter in an SCR-Dependent
Manner. Our findings that MED31 physically interacts with SCR
and plays a critical role in the SCR-regulated expression of
Fig. 3. MED31 acts in the SHR/SCR pathway to regulate ground tissue patterning. (A) RT-qPCR analysis showing the relative expression levels of SHR and SCR
in WT and MED31-RNAi roots. Total RNA was extracted from 5-mm root tip sections of 5 DAG seedlings. Error bars represent SD from three independent
experiments (Student’s t test, *P < 0.05). pSHR::SHR:GFP expression in WT (B and D) and MED31-RNAi (C and E) at 6 DAG is shown. (B and C, Insets) SHR-GFP
levels in endodermal cells are shown in areas surrounded by the white dashed rectangles. Numbers indicate the endodermal-to-stele ratios of SHR-GFP
fluorescence. Arrows in E show variations of SHR-GFP levels in endodermal cells of MED31-RNAi. (Scale bars, 50 μm.) pSCR::GFP:SCR expression in WT (F) and
MED31-RNAi (G) at 6 DAG is shown. (Scale bars, 50 μm.) Root apical meristem phenotypes of WT (H),MED31-RNAi (I), scr-1 (J),MED31-RNAi scr-1 (K), shr-1 (L),
andMED31-RNAi shr-1 (M) at 6 DAG are shown. (H′–M′) Magnifications of stem cell niche areas in H–M. (H–M, Insets) Root radial patterning is shown in areas
surrounded by the white rectangles. Abbreviations: co, cortex; en, endodermis; ep, epidermis; m, mutant cell layer in shr-1 and scr-1; *, irregular cell layer in
MED31-RNAi. (Scale bars, 50 μm.)
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CYCD6;1 prompted us to investigate whether MED31 was
recruited to the CYCD6;1 promoter region bound by SCR (24).
Consistent with a previous report (24), chromatin immunopre-
cipitation (ChIP)-qPCR assays using pSCR::GFP:SCR and anti-
GFP antibodies showed an enrichment peak of SCR at ∼1,000 bp
upstream of the CYCD6;1 promoter (Fig. 4 E, fragment B and
F). Parallel ChIP-qPCR assays using pMED31::MED31:GFP
plants revealed that the enrichment pattern of MED31 on the
CYCD6;1 promoter overlapped with that of SCR (Fig. 4 E, frag-
ment B and G), indicating that MED31 and SCR were recruited
to the same region of the CYCD6;1 promoter. The MED31 en-
richment on the CYCD6;1 promoter was markedly reduced in scr-1
null mutant compared with WT, indicating that the recruitment of
MED31 to the CYCD6;1 promoter is dependent on the function
of SCR (Fig. 4H). Consistently, ChIP-qPCR assays revealed
that MED31 was also recruited to the promoters of other known
SHR/SCR targets in an SCR-dependent manner (SI Appendix,
Fig. S7 A–C).
Considering the established role of Mediator in bridging the
interaction of DNA-bound transcription factors and Pol II for
PIC formation (31, 55), we hypothesized that knockdown of
MED31 could impair the recruitment of Pol II to the CYCD6;1
promoter. ChIP-qPCR assays showed that the recruitment of the
C-terminal domain of Pol II (42, 56) to the CYCD6;1 promoter
was more decreased in MED31-RNAi than in WT (Fig. 4I). This
identified an important role of MED31 in recruiting Pol II to the
CYCD6;1 promoter during the SHR/SCR-regulated transcrip-
tion of this cell cycle gene.
Collectively, our data support a mechanism by which the
physical interaction of MED31 with SCR occurs on SHR/SCR
target promoters, and this interaction is critical for SHR/SCR-
regulated gene transcription.
MED31 Forms a Ternary Complex with SHR and SCR in an SCR-Dependent
Manner.Results showing that MED31 physically interacts with SCR
(Fig. 1 A and B), together with the long-standing observation that
SHR and SCR act as a heterodimer (16), suggested the possibility
that MED31 forms a ternary complex with SHR and SCR in vivo.
To test this, we performed co-IP assays by coexpressing MED31-
myc, SCR, and SHR-GFP in N. benthamiana leaves. As shown in
Fig. 5A, both MED31-myc and SCR coimmunoprecipitated with
SHR-GFP, indicating that MED31 indeed exists in the same com-
plex with SHR and SCR in vivo.
To exclude the possibility that MED31 forms a ternary com-
plex with SHR/SCR through a linkage protein other than SCR,
we performed in vitro pull-down assays using purified MED31-
MBP, GST-SHR, and SCR-FLAG. The results indicated that
MED31-MBP could pull down GST-SHR in the presence of
SCR-FLAG but failed to pull down GST-SHR in the absence of
SCR-FLAG (Fig. 5B). These results substantiated that the for-
mation of the MED31/SCR/SHR ternary complex strictly de-
pends on the interface protein SCR.
The finding that MED31 exists in the same complex with SHR
and SCR in vivo prompted us to investigate the precise details of
their interactions. For this purpose, we first performed in vitro
pull-down assays to examine the interactions of SHR and SCR
with themselves or with each other. The results showed that
GST-SHR could pull down SCR-FLAG, whereas it failed to pull
down SHR-FLAG, indicating that SHR interacts with SCR but
not with itself (Fig. 5C). In parallel experiments, GST-SCR
pulled down SHR-FLAG, whereas it failed to pull down SCR-
FLAG (Fig. 5D), indicating that SCR interacts with SHR but not
with itself. These results are consistent with the notion that SHR
and SCR form a heterodimer involved in the regulation of stem
cell ACD and ground tissue patterning (16). Taken together,
these data support that MED31 forms a ternary complex with
the SHR/SCR heterodimer in vivo, and the SCR interface serves
as a bridge between MED31 and SHR in the MED31/SCR/SHR
ternary complex.
Fig. 4. MED31 is involved in SHR/SCR-regulated spatiotemporal activation of
CYCD6;1. pCYCD6;1::GFP expression in the root stem cell niche of WT (A) and
MED31-RNAi (B) at 4 DAG is shown. (Scale bars, 10 μm.) Expression of
pCYCD6;1::GFP in the root meristem of WT (C) andMED31-RNAi (D) at 6 DAG
is shown. White arrowheads indicate extra cell divisions with pCYCD6;1::GFP
expression. (Scale bars, 50 μm.) (E) Schematic diagram of the CYCD6;1 and PCR
amplicons (indicated as letters A–C) used for ChIP-qPCR. TSS, transcription start
site. ChIP-qPCR results show the enrichment of SCR (F) and MED31 (G) on the
chromatin of CYCD6;1. Sonicated chromatins from 5 DAG seedlings were
precipitated with anti-GFP antibodies (Abcam). The precipitated DNAwas used
as a template for qPCR analysis, with primers targeting different regions of the
CYCD6;1 as shown in E. (H) ChIP-qPCR results showing that SCR mutation im-
pairs the recruitment of MED31 to the promoter regions of SCR targets.
Chromatins were extracted from MED31-GFP and MED31-GFP/scr-1 seedlings
at 5 DAG and precipitated with anti-GFP antibodies, respectively. (I) ChIP-qPCR
results showing that reduction of MED31 impairs Pol II-directed transcription
of CYCD6;1. Chromatin was extracted from WT and MED31-RNAi seedlings at
5 DAG and precipitated with anti-CTD antibodies (Abcam), respectively. In F–I,
the ChIP signal was quantified as the percentage of total input DNA by qPCR.
In F–H, the ChIP signal was normalized to ACT7 in the indicated genotypes,
respectively. In I, the ChIP signal was normalized toWT. Error bars represent SD
from three independent experiments. Asterisks indicate significant differences,
according to Student’s t test (*P < 0.05; **P < 0.01).
















MED31 and SHR Compete with Each Other for Binding to SCR. Since
MED31 (Fig. 1D) and SHR (16) bind the same protein domain of
SCR, we tested whether MED31 and SHR affect each other in
binding SCR. Yeast three-hybrid assays detected the SCR and
MED31 interaction on the selection synthetically defined (SD)
medium SD/-Ade/-His/-Trp/-Leu (SD/-4) (Fig. 6A). Induction of
SHR expression on the selection medium SD/-Ade/-His/-Trp/-
Leu/-Met (SD/-5) abolished the MED31/SCR interaction (Fig.
6A), suggesting that SHR competitively inhibits the MED31/SCR
interaction in yeast cells. In parallel experiments, the SHR/SCR
interaction was detected on the selection medium SD/-4 (Fig. 6A).
Induction of MED31 expression on the selection medium SD/-5
substantially reduced the SHR/SCR interaction (Fig. 6A), sug-
gesting that MED31 also interferes with the SHR/SCR interaction
in yeast cells. These results suggest that SHR and MED31 affect
each other in the interaction with SCR in yeast cells.
To test whether SHR and MED31 compete with each other for
interacting with SCR in vivo, we performed co-IP assays in N.
benthamiana leaves. For these experiments, protein extracts from
N. benthamiana leaves coexpressing MED31-myc and SCR were
incubated with gradients of the separately expressed SHR/GFP
fusion protein and immunoprecipitated with anti-GFP or anti-myc
antibodies. Results indicated that the interaction between MED31-
myc and SCR was weakened by increasing amounts of SHR-GFP
(Fig. 6B). In parallel experiments, the interaction between SHR-
GFP and SCR was only mildly attenuated by increasing amounts of
MED31-myc (SI Appendix, Fig. S8). These results confirmed that
SHR potently impairs the binding of MED31 to SCR in vivo, and
the binding affinity between SHR and SCR is stronger than that
between MED31 and SCR.
We hypothesized that further increased doses of MED31 may
display a competitive effect on the SHR/SCR interaction. To test
this, we performed an in vitro pull-down assay in which the
amounts of the SHR and SCR proteins were kept constant in each
sample, whereas the concentration of MED31 was increased in a
gradient. In this assay, recombinant GST-SHR or MED31-MBP
was used to pull down SCR-FLAG synthesized by in vitro tran-
scription/translation reactions. Results showed that increasing
concentrations (i.e., five- and 10-fold the amount of GST-SHR) of
MED31-MBP reduced the interaction between SCR-FLAG and
GST-SHR (Fig. 6C), validating our hypothesis.
To further substantiate the above observations, we performed a
quantitative in vitro co-IP assay in which synthetic SCR-FLAG was
used to pull down recombinant SHR-MBP and MED31-MBP (Fig.
6D). Low concentrations of MED31-MBP (i.e., 0-, 0.1-, 0.5-, or 1.0-
fold the amount of SHR-MBP) had a minor impact on the in-
teraction between SHR-MBP and SCR-FLAG, whereas higher
doses of MED31-MBP (i.e., five- and 10-fold the amount of SHR-
MBP) reduced the interaction between SHR-MBP and SCR-FLAG
to 0.75- or 0.64-fold compared with control, respectively (fivefold,
0.88/1.18; 10-fold, 0.75/1.18) (Fig. 6D). These results confirmed that
the SHR/SCR interaction was stronger than the MED31/SCR in-
teraction. The differences in the strength of the interaction of
MED31 or SHR with the scaffold protein SCR may affect the dy-
namic formation of the MED31/SCR/SHR ternary complex.
Discussion
MED31 Shows Differential Effects on CYCD6;1 Expression Between
Stem Cells and the Upper Ground Tissue. Our results reveal that
MED31 can act as an activator for CYCD6;1 in the CEI and
CEID, while acting as a repressor in the upper ground tissue, and
that the change in MED31 function likely correlates with different
levels of SHR. We propose a working model to explain the dif-
ferential effects of MED31 in regulating CYCD6;1 expression in
different cell types. In the CEI and CEID, relatively high SHR
protein levels weaken the interaction of MED31 with SCR, and
therefore impair the ability of MED31 to “bridge” the commu-
nication between this “gene-specific” transcriptional activator and
the Pol II general transcription machinery. At this stage, CYCD6;1
expression is shut off (Fig. 6E). In response to developmental
cues, SHR protein levels are relatively low, enabling MED31 to
interact with SCR (impaired in MED31-RNAi) and thereby acti-
vate CYCD6;1 expression (Fig. 6F). This model highlights that the
dynamic movement of SHR into the CEI and CEID could change
the local SHR-to-MED31 protein ratio, which determines the
transcriptional output of the MED31/SCR/SHR ternary complex.
Moreover, our results support that the above scenario also
operates in the upper ground tissue. In the endodermis layer of
WT roots, the SHR protein abundance is relatively high and the
SHR-to-MED31 protein ratio in individual cells is uniformly
controlled to a threshold ratio, which keep the CYCD6;1 ex-
pression in check (SI Appendix, Fig. S9A). However, in the
presumptive endodermis layer of MED31-RNAi roots, the SHR-
to-MED31 protein ratio is impaired, and thereby leads to spo-
radic activation of CYCD6;1 expression (SI Appendix, Fig. S9B).
MED31 Is a Conserved Stem Cell Regulator Between Plants and
Animals. Gene transcription regulated by Pol II plays a crucial
role in stem cell ACD and organ patterning. While much effort is
devoted to gene-specific transcription factors and their transcrip-
tional targets, we know surprisingly little about the function of
protein complexes that interact with Pol II during gene transcrip-
tion, such as the Mediator complex. Here, we provide biochemical
and genetic evidence that the MED31 subunit of the plant Medi-
ator complex is a critical component of the extensively investigated
SHR/SCR transcriptional complex involved in regulating ACD of
Fig. 5. MED31 is an important component of the SHR/SCR complex. (A) Co-IP
assay showing that SHR associates with SCR and MED31 in N. benthamiana.
MED31-myc, SCR, and SHR-GFP were coinfiltrated into N. benthamiana leaves.
Protein samples were immunoprecipitated with anti-GFP antibody and immu-
noblotted with anti-myc and anti-SCR antibodies. MED31-myc– and SCR-
coinfiltrated N. benthamiana leaves were used as negative controls. (B) In
vitro pull-down assays showing that MED31 forms a ternary complex with SHR
and SCR. GST-SHR and SCR-FLAG were pulled down by MED31-MBP immobi-
lized on amylose resin. Proteins bound to amylose resin were eluted and ana-
lyzed by anti-GST and anti-FLAG antibodies, respectively. (C) In vitro pull-down
assays showing that SHR directly interacts with SCR but not itself. SCR-FLAG was
pulled down by GST-SHR immobilized on a GST-Bind resin. Protein bound to the
GST-Bind resin was eluted and analyzed using an anti-FLAG antibody. (D) In
vitro pull-down assay showing that SCR directly interacts with SHR but not itself.
SHR-FLAG was pulled down by GST-SCR immobilized on a GST-Bind resin. Pro-
tein bound to the GST-Bind resin was eluted and analyzed using an anti-FLAG
antibody. CBB, Coomassie brilliant blue staining; MW, molecular weight (mass).
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the CEI/CEID and ground tissue patterning. We further reveal that
MED31 is required for the accurate spatiotemporal activation of
CYCD6;1 expression and is recruited to SHR/SCR target promoters
in an SCR-dependent manner. These data support the notion that
the MED31 interface of Mediator directly links the context-specific
transcriptional activators with the Poll II general transcription ma-
chinery during SHR/SCR-regulated gene transcription.
Although MED31 shows differential effects on CYCD6;1 ex-
pression in stem cells and the upper ground tissue (Fig. 4 C and
D), our RT-qPCR results indicate that this Mediator subunit
generally acts as a positive regulator of SHR/SCR transcriptional
targets, including SCR, SCL3, RLK, JKD, MGP, and NUC (Fig. 3
A, F, and G and SI Appendix, Fig. S5 E–I). In this regard, the
mode of action of MED31 is in contrast to that of the RBR
protein, which also physically binds SCR but negatively regulates
SHR/SCR transcriptional targets (25, 57). Therefore, adding to
the knowledge that RBR acts as a repressor of SHR/SCR activity,
the present study demonstrated that MED31 acts as a coactivator
of SHR/SCR activity. Considering that both MED31 (Fig. 1D) and
RBR (25) bind to the CD of SCR, the relationship between
MED31 and RBR with respect to their binding to SCR needs to
be elucidated in future studies to understand the underlying
mechanism and physiological significance.
Similar to animal MED31, which plays an essential role in
embryonic development (49, 50), we showed that knockout of
MED31 leads to embryonic lethality in Arabidopsis (SI Appendix,
Fig. S3 B–D′). Although the mechanisms underlying the in-
volvement of animal MED31 in stem cell regulation are not fully
understood, the data suggest conserved functions of MED31 in
early embryogenesis between animals and plants. In line with this,
recent structural studies in yeast showed that the highly conserved
MED31 is involved in the formation of a unique structure (i.e.,
MED7/31 submodule) that directly binds the Pol II CTD in the
PIC during transcription initiation (55, 58). Considering that the
MED7 subunit is also conserved between yeast and plants, it is
necessary and important in future studies to explore whether
MED31 functions alone or together with other Mediator subunits,
such as MED7, to regulate root and embryo development.
Considering that the master stem cell regulators SHR and SCR
are plant-specific proteins (6) and the functions of MED31 and
Fig. 6. MED31 and SHR compete with each other for binding to SCR. (A) Yeast three-hybrid (Y3H) assays showing that addition of SHR dramatically reduced
the MED31/SCR interaction (Top two panels) and addition of MED31 reduced the SHR/SCR interaction (Bottom two panels). (Top two panels) Yeast cells
cotransformed with pGADT7-SCR and pBridge-MED31-SHR were dropped onto SD/-Trp/-Leu (SD/-2) and SD/-4 media to assess the MED31/SCR interaction. The
cotransformed yeast cells were dropped onto SD/-5 medium to induce SHR. (Bottom two panels) Yeast cells cotransformed with pGADT7-SHR and pBridge-
SCR-MED31 were dropped onto SD/-2 and SD/-4 media to assess the SHR/SCR interaction. The cotransformed yeast cells were dropped onto SD/-5 medium to
induce MED31. AD, activation domain fusion; BD, binding domain fusion. (B) Co-IP assay showing that the gradually increasing addition of SHR disrupted the
MED31/SCR interaction in N. benthamiana. MED31-myc and SCR were coexpressed in N. benthamiana leaves. SHR-GFP was added to SCR-MED31-myc protein
extracts according to the gradient as shown. Protein samples were immunoprecipitated with anti-GFP antibodies or anti-myc antibodies and immunoblotted
with anti-SCR antibodies to detect the SHR/SCR interaction and MED31/SCR interaction, respectively. MW, molecular weight (mass). (C) In vitro pull-down
assays showing that high concentrations of MED31 affected SHR/SCR interaction. For each sample, the amounts of SCR-FLAG and GST-SHR were equal, and
MED31-MBP was added according to the indicated gradient. SCR-FLAG was pulled down by GST-SHR immobilized on a GST-Bind resin or MED31-MBP
immobilized on an amylose resin. Proteins were eluted and analyzed using an anti-FLAG antibody. (D) In vitro quantitative co-IP assays showing that the
SHR/SCR interaction was stronger than the MED31/SCR interaction. For each sample, the amounts of SCR-FLAG and SHR-MBP were equal, and MED31-MBP
was added according to the indicated gradient. SCR-FLAG was immunoprecipitated with anti-FLAG antibodies and immunoblotted with anti-MBP antibodies
to analyze MED31-MBP and SHR-MBP. Bands were quantified using ImageJ software (NIH). (E and F) Proposed mechanism by which MED31 regulates SHR/
SCR-mediated dynamic activation of CYCD6;1 in the CEI and CEID. (E) When the relative protein abundance between SHR and MED31 is high enough to
prevent MED31/SCR interaction, CYCD6;1 expression is turned off. (F) When the relative protein abundance between SHR and MED31 is low enough to enable
MED31/SCR interaction, CYCD6;1 expression is turned on.
















RBR can be conserved in plants and animals (57), the present
results support a scenario in which the regulators SHR and SCR
that specify stem cells are recruited from plant-specific protein
families, whereas their coactivator (i.e., MED31) or repressor (i.e.,
RBR) is conserved between the plant and animal kingdoms.
The Dynamic Formation of the MED31/SCR/SHR Ternary Complex
Controls the Spatiotemporal Transcriptional Output of SHR/SCR. Al-
though it is generally believed that SHR and SCR function as
transcriptional regulators, the precise details by which these
GIBBERELLIC-ACID INSENSITIVE (GAI), REPRESSOR
of GAI (RGA), and SCR (GRAS) family proteins activate target
gene transcription remain largely unknown. Consistently, a re-
cent structural study suggested that SHR and SCR function as
transcriptional cofactors that indirectly bind to their target pro-
moters via their interacting BIRD transcription factors (22).
We explored the mechanism underlying the regulation of the
transcriptional output of SHR/SCR by linking SHR/SCR with
the Mediator complex. We provided evidence that MED31 is
involved in the dynamic formation of a MED31/SCR/SHR ter-
nary complex. We used the well-established SHR/SCR/CYCD6;1
transcriptional module to demonstrate how the dynamic ternary
complex strictly controls the spatiotemporal transcriptional output
of SHR/SCR (Fig. 6 E and F). The fact that MED31 directly binds
the Pol II CTD in the PIC during transcription initiation (55)
suggests that the transcriptional output of SHR/SCR is only turned
on when MED31 physically interacts with SCR (presumably the
abundance of MED31 is high enough at this stage to compete with
SHR for binding to SCR). This stage is the only one at which
MED31 can recruit the Pol II general transcriptional machinery to
SHR/SCR target promoters for PIC formation. The transcriptional
output of SHR/SCR is turned off when MED31 is unable to
physically interact with SCR (presumably the SHR abundance is
high enough at this stage to compete with MED31 for binding to
SCR). At this stage, the Pol II general transcriptional machinery
cannot be recruited to SHR/SCR target promoters.
MED31 and SHR affect each other for binding to SCR, and
the interaction between SHR and SCR is stronger than that
between MED31 and SCR (Fig. 6). Therefore, our model pre-
dicts that the relative protein abundance of SHR and MED31 in
the CEI and CEID may serve as an important parameter that
affects the dynamic formation of the MED31/SCR/SHR ternary
complex, which eventually determines the transcriptional output
of SHR/SCR. In line with this prediction, it is well-recognized
that SHR acts as a mobile, dose-dependent signal, and its protein
can move from the stele to the CEI and CEID (16). In addition,
SHR protein can be degraded during cell division (25), and our
data indicated that MED31 is subject to proteasome-dependent
degradation (SI Appendix, Fig. S2 E–G). In this context, we
speculate that, in response to developmental cues, the relative
protein abundance of SHR and MED31 in the CEI and CEID
changes dynamically, switching the transcriptional output of
SHR/SCR on or off. It will be very interesting in future studies to
elucidate how the relative protein abundance of SHR and
MED31 is regulated in response to developmental cues.
Furthermore, we revealed a critical function of MED31 in
maintaining the uniform distribution of the SHR protein in each
endodermis cell (Fig. 3 C and E). Notably, in the presumptive
endodermis layer of MED31-RNAi roots, variations of SHR pro-
tein abundance always correlate with ectopic activation of
CYCD6;1 expression (Fig. 4D), as well as with irregular periclinal
division of the corresponding cells (Fig. 3 C and E), suggesting
that the MED31/SCR/SHR ternary complex also operates in
regulating the patterning of the upper ground tissue. In line with
this scenario, it has been elegantly shown that SHR acts in a dose-
dependent manner to regulate CYCD6;1 expression and promotes
periclinal divisions to form middle cortex along the endodermis
(54). Considering that SCR plays a pivotal role in regulating SHR
movement and nuclear residence (16) and that MED31 physically
and functionally interacts with SCR (this study), it is reasonable to
speculate that the function of MED31 in maintaining the uniform
endodermal distribution of SHR is achieved through collaboration
with its interacting partner SCR. It is of great importance in future
studies to explore the underlying mechanisms.
Materials and Methods
All seedlings were grown on half-strength Murashige and Skoog medium
with 1% sucrose under a 16-h light/8-h dark cycle at 22 °C. Plant materials,
plasmid construction methods, cytological techniques, biochemical methods,
and all other experimental procedures are described in SI Appendix, Sup-
plementary Materials and Methods.
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